Mikhail Blagosklonny is the Editor-in-Chief at Oncotarget, a proffessor of Oncology, and a researcher who has published plenty of information about aging. He has also been studying cancer and how it can be treated therapeutically for many years and is well-known for supporting Rapamycin, which is a cancer drug that may increase the length of years that a person can live. His work in the field of science will be appreciated by those who benefit from it for years to come.
Sirolimus, which is another name for Rapamycin has been used to make organ transplants go smoother, as a cancer drug, to treat unique diseases that effect the lungs, and to coat coronary stents. Years ago it was found to have immunity boosting properties as well as anti-fungal abilities. One of the amazing things about the drug is the fact that it is much less toxic to the liver than most other drugs that help organ transplants to not be rejected by the body. It is also used to treat hemolytic-uremic syndrome but mainly when people get a kidney transplant due to the syndrome. Many times, the new kidney can be effected by the old kidney, during transplant, and the new kidney can contract hemolytic-uremic syndrome. Rapamycin prevents this from happening. Follow Mikhail on Google Scholar.
Mikhail Blagosklonny has proven through tests on mice that Rapamycin helps to fight tuberculosis as they age. He also is continuing to champion Rapamycin as an anti-aging drug despite inconclusive evidence, so far. On this front, there is ongoing research on marmoset monkeys to show that it can treat Alzheimer’s disease as well as Muscular Dystrophy. On top of this the drug has been shown to be a possible cure for SLE as it blocks the activation of certain compounds that are a part of the disease. Read more on templeofthecave.com.
Dr. Mikhail Blagosklonny has always hoped that people worldwide would be able to get the kind of medical care they deserve, no matter how rich or poor they are. His work in the field of cancer has been invaluable, and he also continues to make large contributions in the field of aging. His interest in these two fields stems from the fact that older people are usually more prone to get cancer. It is good that there is someone like Mikhail Blagosklonny in the world, because it is people like him that inspire others to do great things. His tireless work in his field of study has not gone unnoticed, and many of his students and colleagues have been motivated to add to the work he has done. This will surely help to bring more possible cures and treatments for aging and cancer.
Something unique about Mikhail Blagosklonny is his desire to not just treat cancer but to do it in a way that is less painful and expensive for the patients who must suffer through it. He hopes to find the way to destroy cancer cells in the body while keeping normal cells healthy at the same time. He knows that this will help patients to be able to stay in good physical and mental health while going through treatment, and this attitude of his has brought him much attention from the media.